PAFAH1B3 Products

Description

Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID

5050

Alternate Names

EC 3.1.1.47 FLJ44990 PAF acetylhydrolase 29 kDa subunit PAF-AH 29 kDa subunit PAFAH subunit gamma PAF-AH subunit gamma PAF-AH1b alpha 1 subunit PAFAHG platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) platelet-activating factor acetylhydrolase IB subunit gamma platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit (29kD) platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa)

Research Areas for PAFAH1B3

Find related products by research area and learn more about each of the different research areas below.

Neuroscience